Merrimack Pharmaceuticals, Inc. EBITDA 2012-2024 | MACK
Merrimack Pharmaceuticals, Inc. ebitda from 2012 to 2024. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
| Merrimack Pharmaceuticals, Inc. Annual EBITDA (Millions of US $) |
|
|---|---|
| 2023 | $-2 |
| 2022 | $-2 |
| 2021 | $-2 |
| 2020 | $-3 |
| 2019 | $-20 |
| 2018 | $-62 |
| 2017 | $-91 |
| 2016 | $-142 |
| 2015 | $-142 |
| 2014 | $-63 |
| 2013 | $-118 |
| 2012 | $-89 |
| 2011 | $-76 |
| 2010 | $-46 |
| 2009 | $-45 |
| Merrimack Pharmaceuticals, Inc. Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2024-03-31 | $-1 |
| 2023-12-31 | $-0 |
| 2023-09-30 | $-1 |
| 2023-06-30 | $-1 |
| 2023-03-31 | $-0 |
| 2022-12-31 | $-1 |
| 2022-09-30 | $-1 |
| 2022-06-30 | $-0 |
| 2022-03-31 | $-0 |
| 2021-12-31 | $-0 |
| 2021-09-30 | $-1 |
| 2021-06-30 | $-1 |
| 2021-03-31 | $-1 |
| 2020-12-31 | $-1 |
| 2020-09-30 | $-1 |
| 2020-06-30 | $-1 |
| 2020-03-31 | $0 |
| 2019-12-31 | $-2 |
| 2019-09-30 | $-1 |
| 2019-06-30 | $-8 |
| 2019-03-31 | $-9 |
| 2018-12-31 | $-14 |
| 2018-09-30 | $-16 |
| 2018-06-30 | $-16 |
| 2018-03-31 | $-16 |
| 2017-12-31 | $-15 |
| 2017-09-30 | $-16 |
| 2017-06-30 | $-34 |
| 2017-03-31 | $-26 |
| 2016-12-31 | $-41 |
| 2016-09-30 | $-34 |
| 2016-06-30 | $-35 |
| 2016-03-31 | $-33 |
| 2015-12-31 | $9 |
| 2015-09-30 | $-36 |
| 2015-06-30 | $-18 |
| 2015-03-31 | $-29 |
| 2014-12-31 | $-5 |
| 2014-09-30 | $-23 |
| 2014-06-30 | $-13 |
| 2014-03-31 | $-23 |
| 2013-12-31 | $-28 |
| 2013-09-30 | $-35 |
| 2013-06-30 | $-28 |
| 2013-03-31 | $-27 |
| 2012-12-31 | $-24 |
| 2012-09-30 | $-23 |
| 2012-06-30 | $-19 |
| 2012-03-31 | $-23 |
| 2011-12-31 | $-17 |
| 2011-09-30 | $-17 |
| 2011-06-30 | $-28 |
| 2011-03-31 | $-13 |
